Request Appointment
1 Gustave Levy PlaceNew York, NY 10029
Overview of Dr. Doroshow
Dr. Deborah Doroshow is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, and Mount Sinai Beth Israel. She received her medical degree from Harvard Medical School and has been in practice 12 years. She is one of 182 doctors at The Mount Sinai Hospital and one of 69 doctors at Mount Sinai West who specialize in Oncology. She has more than 40 publications and over 500 citings.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2015 - 2020- Yale-New Haven Medical CenterResidency, Internal Medicine, 2013 - 2015
Harvard Medical SchoolClass of 2013
Yale UniversityPh.D., History of Medicine, 2007 - 2012
Certifications & Licensure
NY State Medical License 2019 - 2027
NJ State Medical License 2022 - 2025
CT State Medical License 2015 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
- Pembrolizumab for Advanced NSCLC and PS 2-3 Start of enrollment: 2023 May 26
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting.Mansi Saxena, Thomas U Marron, Julia Kodysh, John P Finnigan, Sayali Onkar
Cancer Discovery. 2025-03-17 - Olaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer ...Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho
Cancer. 2025-02-15 - 1 citationsInpatient Immunotherapy Outcomes Study: A Multicenter Retrospective Analysis.Fauzia Riaz, John L Vaughn, Huili Zhu, James C Dickerson, Hoda E Sayegh
JCO Oncology Practice. 2025-02-12
Press Mentions
‘Are We Giving False Hope?’: Few Hospitalized People with Cancer Benefit from ImmunotherapyApril 7th, 2025- Are Immune Checkpoint Inhibitors Effective in Hospitalized Patients with Cancer?February 18th, 2025
- Mount Sinai-Led Study Suggests Common Cancer Treatment Does Not Work Well for Hospitalized PatientsFebruary 13th, 2025
- Join now to see all
Grant Support
- TCI Early Career Cancer Clinical Investigator AwardICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2015–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
